Retrospective Cohort Study: Prevalence and predictors of Pseudomonas aeruginosa among hospitalized patients with diabetic foot infections.
24 Jun, 2022 | 10:43h | UTC
Commentary on Twitter
Should Empiric DFI treatment include coverage for Pseudomonas aeruginosa?
?⚡Multicenter, retrospective cohort @OFIDJournal
257(88%) patients received empiric antibiotics active against PsA, but only 27 (9%) patients had PsA DFI #IDTwitter @BradSpellberg https://t.co/Ef5vD50LOD— Antibiotic Steward Bassam Ghanem?? (@ABsteward) June 17, 2022